• This record comes from PubMed

Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary

. 2020 Jun ; 65 (3) : 483-490. [epub] 20191104

Language English Country United States Media print-electronic

Document type Journal Article

Links

PubMed 31686360
PubMed Central PMC7244397
DOI 10.1007/s12223-019-00751-x
PII: 10.1007/s12223-019-00751-x
Knihovny.cz E-resources

Excessive use of antibiotics contributes to the selection of resistant bacteria and intestinal colonization with multiresistant pathogens poses a risk factor for subsequent infections. The present study assessed vancomycin-resistant enterococci (VRE) carriage rates in patients admitted to our tertiary care hospital. Stool samples sent for routine culturing were screened with vancomycin containing solid or broth enrichment media. VRE isolates were identified with matrix-assisted laser desorption/ionization-time of flight mass spectrometry and antibiotic susceptibilities were tested by E-test. Vancomycin resistance genes were detected by polymerase chain reaction. Medical records of carriers were examined for suspected risk factors for colonization. Altogether 3025 stool specimens were analyzed. Solid media identified a VRE carriage rate of 2.2% while broth enrichment detected 5.8%. Seventy percent of the isolates were Enterococcus faecium. VanB genotype was detected in 38.2%, VanA in 37.3%, VanC1 in 22.6%, and VanC2 in 1.9%. All VRE were sensitive to linezolid, daptomycin, and tigecycline. Collective risk factors for carriage were diabetes, normal flora absence, Clostridioides difficile positivity, longer hospital stay, and advanced age. 78.5% of the carriers received antibiotic therapy which was metronidazole in most cases (47.3%). We recommend regular screening of risk groups such as patients with diabetes, history of recent hospitalization, or former C. difficile infection as an imperative step for preventing VRE dissemination.

See more in PubMed

Alevizakos M, Gaitanidis A, Nasioudis D, et al. Colonization with vancomycin-resistant enterococci and risk for bloodstream infection among patients with malignancy: a systematic review and meta-analysis. Open Forum Infect Dis. 2016;4(1):ofw246. PubMed PMC

Amberpet R, Sistla S, Parija SC, et al. Screening for intestinal colonization with vancomycin resistant enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital. J Clin Diagn Res. 2016;10(9):06–09. PubMed PMC

Böröcz K, Szilágyi E, Kurcz A, et al. First vancomycin-resistant Enterococcus faecium outbreak reported in Hungary. Euro Surveill. 2005;10(1):E050127.1. PubMed

Carbonnelle E, Mesquita C, Bille E, et al. MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory. Clin Biochem. 2011;44(1):104–109. PubMed

Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13(4):686–707. PubMed PMC

Cheng VCC, Chen JHK, Tai JWM, et al. Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature. BMC Infect Dis. 2014;14:514. PubMed PMC

D’Agata EMC, Jirjis J, Gouldin C, et al. Community dissemination of vancomycin-resistant Enterococcus faecium. Am J Infect Control. 2001;29(5):316–320. PubMed

Depardieu F, Perichon B, Courvalin P. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol. 2004;42(12):5857–5860. PubMed PMC

Dina J, Malbruny B, Leclercq R, et al. Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A. Antimicrob Agents Chemother. 2003;47(7):2307–2309. PubMed PMC

Dombrádi Z, Dobay O, Nagy K, et al. Prevalence of vanC vancomycin-resistant enterococci in the teaching hospitals of the University of Debrecen, Hungary. Microb Drug Resist. 2012;18(1):47–51. PubMed

Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925–1932. PubMed PMC

European Centre for Disease Prevention and Control . Annual epidemiological report 2016: healthcare-associated infections acquired in intensive care units. Stockholm: ECDC; 2016.

European Centre for Disease Prevention and Control . Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) Stockholm: ECDC; 2017. Surveillance of antimicrobial resistance in Europe 2016.

Franyó D, Kocsi B, Lesinszki V, et al. Characterization of clinical vancomycin-resistant Enterococcus faecium isolated in Eastern Hungary. Microb Drug Resist. 2018;24:10. PubMed

Gambarotto K, Ploy MC, Turlure P, et al. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France. J Clin Microbiol. 2000;38(2):620–624. PubMed PMC

Gekenidis MT, Studer P, Wüthrich S, et al. Beyond the matrix-assisted laser desorption ionization (MALDI) biotyping workflow: in search of microorganism-specific tryptic peptides enabling discrimination of subspecies. Appl Environ Microbiol. 2014;80(14):4234–4241. PubMed PMC

Ghidán Á, Csiszár K, Cs J, et al. PCR detection of the vanA gene in a vancomycin-resistant Enterococcus faecalis. J Antimicrob Chemother. 2000;46:325–326. PubMed

Ghidán A, Dobay O, Kaszanyitzky EJ, et al. Vancomycin resistant enterococci (VRE) still persist in slaughtered poultry in Hungary 8 years after the ban on avoparcin. Acta Microbiol Immunol Hung. 2008;55(4):409–417. PubMed

Howden BP, Holt KH, Lam MMC, et al. Genomic insights to control the emergence of vancomycin-resistant enterococci. mBio. 2013;4(4):412–413. PubMed PMC

Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998;4(2):239–249. PubMed PMC

Ieven M, Vercauteren E, Descheemaeker P, et al. Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients. J Clin Microbiol. 1999;37(5):1436–1440. PubMed PMC

Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev. 1994;7(4):462–478. PubMed PMC

Karki S, Houston L, Land G, et al. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012;1:31. PubMed PMC

Kaszanyitzky EJ, Tenk M, Ghidán A, et al. Antimicrobial susceptibility of enterococci strains isolated from slaughter animals on the data of Hungarian resistance monitoring system from 2001 to 2004. Int J Food Microbiol. 2007;115(1):119–123. PubMed

Leclercq R, Derlot E, Duval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319(3):157–161. PubMed

Libisch B, Lepsanovic Z, Top J, et al. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia. Scand J Infect Dis. 2008;40(10):778–784. PubMed

Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362–386. PubMed

Nelson I, Higuita A, Huycke MM. Enterococcal disease, epidemiology, and implications for treatment. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. Boston: Massachusetts Eye and Ear Infirmary; 2014. PubMed

Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992;72:195–198. PubMed

Novicki TJ, Schapiro JM, Ulness BK, et al. Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material. J Clin Microbiol. 2004;42(4):1637–1640. PubMed PMC

Özsoy S, İlki A. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing. Braz J Microbiol. 2017;48(3):489–492. PubMed PMC

Purohit G, Gaind R, Dawar R, et al. Characterization of vancomycin resistant enterococci in hospitalized patients and role of gut colonization. J Clin Diagn Res. 2017;11(9):DC01–DC05. PubMed PMC

Seng P, Drancourt M, Gouriet F, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009;49(4):543–551. PubMed

Sohn KM, Peck KR, Joo EJ, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis. 2013;17(4):e240–e246. PubMed

Stosor V, Peterson LR, Postelnick M, et al. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med. 1998;158(5):522–527. PubMed

The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Published 2017. Version 7.1. Accessed 10 Dec 2018

Top J, Willems R, Bonten M. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol. 2008;52:297–308. PubMed

Uttley AH, Collins CH, Naidoo J, et al. Vancomycin-resistant enterococci. Lancet. 1988;1(8575-6):57–58. PubMed

Yean CY, Yin LS, Lalitha P, et al. A nanoplex PCR assay for the rapid detection of vancomycin and bifunctional aminoglycoside resistance genes in Enterococcus species. BMC Microbiol. 2007;7:112. PubMed PMC

Zhou M.J., Li J., Salmasian H., Zachariah P., Yang Y-X., Freedberg D.E. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition. Journal of Hospital Infection. 2019;101(1):69–75. PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...